Elsie Cheang
Lawyers
Filters
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
Xponential Fitness $120 million IPO and $200 million convertible offering
We advised Xponential Fitness on its concurrent IPO, NYSE listing and convertible preferred offering
Aligos Therapeutics $83.6 million follow-on offering
We advised the underwriters on the stock offering
Theravance Biopharma $100.5 million follow-on offering
We advised the underwriters on the equity offering
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing